Course Content
Multi-System Module — 3rd Year MBBS
AIM EXAM REASONING

KMU Past Paper Practice

Sympatholytic Drugs: Alpha, Beta and Mixed Adrenoceptor Antagonists

3rd Year MBBS • 20 A-type Single Best Answer MCQs

MCQ 1

Question:

A 48-year-old man with episodic severe hypertension due to excess catecholamine release requires a short-acting α-adrenoceptor antagonist for rapid, reversible receptor blockade. Which drug best fits this requirement?

Options:

Phenoxybenzamine
Phentolamine
Prazosin
Tamsulosin
Carvedilol
Correct Answer: Phentolamine
Explanation: Phentolamine produces short-acting, reversible non-selective α blockade, making it suitable when rapid control of catecholamine-mediated vasoconstriction is required.

MCQ 2

Question:

A 67-year-old man has hypertension together with symptoms of benign prostatic hyperplasia. His physician chooses a drug that can reduce vascular resistance while also relaxing smooth muscle at the bladder outlet. Which drug is most appropriate?

Options:

Timolol
Propranolol
Phentolamine
Doxazosin
Betaxolol
Correct Answer: Doxazosin
Explanation: Doxazosin blocks α₁ receptors, producing both vascular smooth-muscle relaxation and relaxation of prostate and bladder-neck smooth muscle.

MCQ 3

Question:

A patient taking an α₁-adrenoceptor antagonist for hypertension complains of persistent nasal stuffiness despite having no respiratory infection. Which pharmacological effect most likely accounts for this symptom?

Options:

Dilatation of nasal mucosal vessels
Contraction of bronchial smooth muscle
Reduced secretion from nasal glands
Stimulation of vascular β₁ receptors
Blockade of bronchial β₂ receptors
Correct Answer: Dilatation of nasal mucosal vessels
Explanation: α₁ blockade reduces vascular tone in the nasal mucosa, producing vasodilation and congestion perceived as nasal stuffiness.

MCQ 4

Question:

A 64-year-old man treated with an α-adrenoceptor antagonist reports that his urinary symptoms have improved but ejaculation has become abnormal. Which drug action most directly explains this adverse effect?

Options:

Blockade of cardiac β₁ receptors
Stimulation of vascular β₂ receptors
Inhibition of renal β₁ receptors
Blockade of presynaptic β₂ receptors
Blockade of genitourinary α₁ receptors
Correct Answer: Blockade of genitourinary α₁ receptors
Explanation: α₁ receptors participate in smooth-muscle contraction during emission and ejaculation; their blockade may therefore disturb normal ejaculatory function.

MCQ 5

Question:

During revision, a student groups phenoxybenzamine and phentolamine together because both interfere with more than one alpha-receptor subtype. Which classification best describes this pair?

Options:

Selective α₁A antagonists
Selective β₁ antagonists
Non-selective α antagonists
Mixed α₁ and β antagonists
Selective α₂ antagonists
Correct Answer: Non-selective α antagonists
Explanation: Phenoxybenzamine and phentolamine block both α₁ and α₂ adrenoceptors and are therefore classified as non-selective alpha antagonists.

MCQ 6

Question:

A hypertensive patient is prescribed a β₁-selective blocker that retains weak partial agonist activity at beta receptors. Which drug has this combination of properties?

Options:

Nadolol
Acebutolol
Timolol
Bisoprolol
Carvedilol
Correct Answer: Acebutolol
Explanation: Acebutolol is relatively β₁ selective and has intrinsic sympathomimetic activity, meaning that it behaves as a partial agonist while blocking stronger catecholamine effects.

MCQ 7

Question:

A patient with glaucoma also has a tendency to develop bronchospasm. The ophthalmologist prefers a topical beta blocker with relative β₁ selectivity rather than a non-selective agent. Which drug is most appropriate?

Options:

Betaxolol
Timolol
Pindolol
Propranolol
Nadolol
Correct Answer: Betaxolol
Explanation: Betaxolol is a β₁-selective beta blocker used topically in glaucoma and produces less bronchial β₂ blockade than non-selective ophthalmic agents.

MCQ 8

Question:

A 58-year-old man recovering after myocardial infarction is prescribed a suitable beta blocker. Which pharmacological effect contributes most directly to protection from catecholamine-related cardiac complications?

Options:

Enhanced myocardial automaticity
Increased ventricular contractility
Increased sympathetic cardiac drive
Reduced cardiac adrenergic stimulation
Enhanced renin secretion
Correct Answer: Reduced cardiac adrenergic stimulation
Explanation: Beta blockade reduces catecholamine-driven heart rate, workload and arrhythmogenic stimulation, which is beneficial after myocardial infarction.

MCQ 9

Question:

A man with ischemic heart disease stops long-term propranolol abruptly because he feels well. Soon afterward, he develops marked palpitations and worsening chest discomfort. Which mechanism best explains this deterioration?

Options:

Persistent α₁-receptor blockade
Progressive muscarinic stimulation
Reduced synthesis of catecholamines
Persistent inhibition of renin release
Exaggerated response to endogenous catecholamines
Correct Answer: Exaggerated response to endogenous catecholamines
Explanation: Abrupt withdrawal after chronic beta blockade can expose sensitized adrenergic pathways to catecholamines, producing rebound tachycardia and worsening ischemic symptoms.

MCQ 10

Question:

A patient recently started on a beta blocker reports that climbing stairs now causes earlier fatigue despite adequate control of his blood pressure. Which physiological response has most likely been limited?

Options:

Reflex contraction of the bladder neck
Vasoconstriction through vascular α₁ receptors
Sympathetic increase in cardiac output during exercise
Parasympathetic slowing of the sinus node
α₂-mediated inhibition of transmitter release
Correct Answer: Sympathetic increase in cardiac output during exercise
Explanation: Beta blockade limits the normal exercise-induced increases in heart rate and contractility, reducing the ability to raise cardiac output during exertion.

MCQ 11

Question:

A 70-year-old man has a markedly prolonged atrioventricular conduction time on ECG and a slow ventricular rate. Which property of beta blockers makes their use particularly hazardous in this patient?

Options:

Reduction of peripheral α₁ tone
Further slowing of AV nodal conduction
Relaxation of prostate smooth muscle
Increase in β₂-mediated bronchodilation
Increase in renin secretion
Correct Answer: Further slowing of AV nodal conduction
Explanation: Beta blockers reduce AV nodal conduction, so significant pre-existing conduction block may worsen and is an important contraindication.

MCQ 12

Question:

A 72-year-old man presents with acute worsening heart failure, pulmonary congestion and poor peripheral perfusion. Starting a beta blocker at this stage may worsen his condition primarily through which action?

Options:

Increasing renin release
Increasing peripheral α₁ tone
Increasing myocardial oxygen demand
Enhancing cardiac automaticity
Reducing myocardial contractility
Correct Answer: Reducing myocardial contractility
Explanation: Acute beta blockade has a negative inotropic effect and can worsen pump failure in an unstable patient with acute decompensated heart failure.

MCQ 13

Question:

A middle-aged patient with pre-existing dyslipidemia is being considered for long-term beta-blocker therapy. Which metabolic change is a recognized limitation of some drugs in this class?

Options:

Higher triglycerides with lower HDL cholesterol
Lower triglycerides with higher LDL cholesterol
Higher HDL cholesterol with lower triglycerides
Lower LDL cholesterol with higher HDL cholesterol
Reduced triglycerides with unchanged HDL cholesterol
Correct Answer: Higher triglycerides with lower HDL cholesterol
Explanation: Some beta blockers may unfavorably alter lipid metabolism by increasing triglycerides and reducing HDL cholesterol, which matters in patients with dyslipidemia.

MCQ 14

Question:

A patient with markedly elevated arterial pressure requires an agent that decreases peripheral resistance through α₁ blockade while simultaneously limiting sympathetic cardiac effects through beta blockade. Which drug is most appropriate?

Options:

Prazosin
Metoprolol
Labetalol
Tamsulosin
Phentolamine
Correct Answer: Labetalol
Explanation: Labetalol combines α₁-mediated vasodilation with beta blockade and is useful in hypertension, particularly when effective blood-pressure control is required.

MCQ 15

Question:

A patient with significant chronic liver dysfunction is prescribed propranolol. Which pharmacokinetic feature makes alteration of drug exposure particularly relevant in this patient?

Options:

Complete elimination unchanged in urine
Minimal absorption from the intestine
Predominant excretion through the lungs
Extensive metabolism in the liver
Failure to enter systemic circulation
Correct Answer: Extensive metabolism in the liver
Explanation: Propranolol undergoes extensive hepatic metabolism, so impaired liver function can alter its metabolism and systemic exposure.

MCQ 16

Question:

A pharmacology student traces the disposition of propranolol after it has undergone hepatic biotransformation. Through which route are its metabolites mainly eliminated?

Options:

Exhaled air
Kidneys
Sweat glands
Salivary glands
Gastric mucosa
Correct Answer: Kidneys
Explanation: Propranolol is extensively metabolized in the liver, after which its metabolites are eliminated mainly through the kidneys.

MCQ 17

Question:

An ophthalmic beta blocker used to lower intraocular pressure also possesses intrinsic sympathomimetic activity. Which drug best matches these properties?

Options:

Betaxolol
Timolol
Propranolol
Nadolol
Carteolol
Correct Answer: Carteolol
Explanation: Carteolol is an ophthalmic beta blocker that can reduce aqueous humor formation and is also among the beta blockers possessing intrinsic sympathomimetic activity.

MCQ 18

Question:

A clinically stable patient with chronic systolic heart failure requires a β₁-selective blocker with established long-term usefulness in this condition. Which drug is an appropriate choice?

Options:

Long-acting metoprolol
Pindolol
Timolol
Acebutolol
Nadolol
Correct Answer: Long-acting metoprolol
Explanation: Appropriate long-acting metoprolol is among the beta blockers with established benefit in clinically stable chronic heart failure.

MCQ 19

Question:

During a discussion of beta-receptor pharmacology, a student is asked to identify a pair of clinically used beta blockers known to demonstrate inverse agonist behavior rather than partial agonist activity. Which pair is most appropriate?

Options:

Pindolol and acebutolol
Carteolol and pindolol
Acebutolol and carteolol
Metoprolol and carvedilol
Pindolol and penbutolol
Correct Answer: Metoprolol and carvedilol
Explanation: Metoprolol and carvedilol are examples of beta blockers demonstrating inverse agonist behavior, whereas pindolol and acebutolol are associated with partial agonist activity.

MCQ 20

Question:

Two patients require mixed adrenoceptor antagonists. One needs effective treatment of markedly elevated blood pressure, while the other has clinically stable chronic heart failure. Which drug pairing best matches these respective clinical priorities?

Options:

Carvedilol followed by tamsulosin
Prazosin followed by labetalol
Labetalol followed by carvedilol
Metoprolol followed by phentolamine
Timolol followed by doxazosin
Correct Answer: Labetalol followed by carvedilol
Explanation: Labetalol is particularly useful for hypertension, while carvedilol is a mixed α₁/β antagonist with established benefit in stable chronic heart failure.
Scroll to Top
💬 WhatsApp Support